GlobeNewswire

Rakovina Therapeutics Secures Exclusive Worldwide Licence to Artemis.AI™ Platform for DNA-Damage Response Oncology Drug Discovery
10/11/2026
Perpetual, royalty-free, exclusive licence for DDR oncology including all future platform improvements, in exchange for C$1.0 million in Rakovina shares VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
TETmedical Appoints Dr. Hooman Kamel and Dr. Evan Gerber as Medical Advisors
10/11/2026
Leading Vascular Neurologist and Emergency Physician Bring Front-Line Stroke Expertise as TETmedical Advances NSE-FAST® Through Its Pivotal Study FAIR HAVEN, N.J. and ITHACA, N.Y., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
Valneva annonce un taux de séroréponse de 94% cinq ans après une dose unique du vaccin contre le chikungunya IXCHIQ®
10/11/2026
94% des participants ont maintenu une séroréponse cinq ans après une dose unique du vaccin La persistance des anticorps chez les adultes âgés de 65 ans et plus est comparable à celle des jeunes adultes Ces données [...]
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ®
10/11/2026
94% of participants maintained seroresponse five years after a single vaccination Comparable antibody persistence observed in older (65+) and younger adults Data further reinforce IXCHIQ ® 's differentiated profile with [...]
Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026
10/11/2026
Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key biomarkers Phase III PrevenTRON study design specifics for trontinemab in preclinical [...]
Trogenix appoints industry veterans John Young as Chair and Josh Murray as Non-Executive Director to support global strategy, commercial foundation and patient access
10/11/2026
John brings more than 35 years of operational and commercial leadership with extensive experience in bringing medicines to market at global scale Josh brings deep capital markets and strategic experience to support the [...]
TME Pharma fournit davantage de détails sur l'accord de négociation exclusif conclu avec TMS Co., Ltd. concernant le NOX-A12
10/11/2026
TME Pharma fournit davantage de détails sur l'accord de négociation exclusif conclu avec TMS Co., Ltd. concernant le NOX-A12 Berlin, Allemagne, le 10 novembre 2026, 8h30 CET – TME Pharma N.V. (Euronext Growth Paris: [...]
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12
10/11/2026
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12 Berlin, Germany, November 10, 2026, 8.30 am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech- [...]
TECregen Strengthens Management Team and Board to Advance Thymus Regeneration and Lead Program TEC001
10/11/2026
Elisabeth Svanberg, MD, PhD, appointed Chief Medical Officer, adding extensive global clinical-development and regulatory expertise Thomas Hanke, PhD, joins the Board, bringing more than 30 years of immunology, drug- [...]
CVMP adopts a positive opinion for SCOVELLA®, the first therapy for hyperinsulinaemia in horses with Equine Metabolic Syndrome
10/11/2026
SCOVELLA ® was developed to reduce hyperinsulinaemia in insulin-dysregulated horses, a key underlying driver of laminitis – a common, painful inflammatory condition in horses’ hooves and significant unmet need in equine [...]
Disclosure of the Total Number of Voting Rights and Shares Forming the Share Capital
10/11/2026
NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL DISCLOSURE OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES FORMING THE SHARE CAPITAL Article 223-16 du Règlement général de l’Autorité des Marchés [...]
Nombre d’actions et de droits de vote composant le capital social
10/11/2026
NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL DISCLOSURE OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES FORMING THE SHARE CAPITAL Article 223-16 du Règlement général de l’Autorité des Marchés [...]
UsAgainstAlzheimer’s Names Danielle Carnival, Ph.D., Chief Executive Officer; Co-Founder George Vradenburg Continues as Executive Chairman
10/11/2026
Appointment builds on momentum and urgency in the fight to end Alzheimer’s WASHINGTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s (UsA2) today announced the appointment of Danielle Carnival, Ph.D., as Chief [...]
Australian ALS therapy aimed at halting disease progression and restoring function advances to Phase 2 trial
10/11/2026
Video interviews, overlay and photos here BRISBANE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- An Australian-developed therapy aimed at halting the progression of amyotrophic lateral sclerosis (ALS) and restoring [...]
Dimora Medical Supports Empower HS 2026, Advancing Everyday Wound Care for the HS Community
10/11/2026
Silicone foam dressings featuring MegaSorb™ technology were included in attendee gift bags to support at-home management of exuding wounds New York, USA, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Dimora Medical, a pioneer in [...]
MaxCyte to Acquire Akron Bio, Expanding its Offerings Across Cell Therapy Manufacturing and Expecting to Nearly Double Revenue Base
10/11/2026
Akron Bio is a leading supplier of GMP-grade reagents and ancillary materials Expands MaxCyte’s footprint across the cell therapy manufacturing workflow and establishes a combined portfolio supporting five commercially [...]
Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
10/11/2026
MELBOURNE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) today announced that it has engaged LifeSci Capital to serve as its exclusive financial advisor to assist in evaluation of [...]
Codexis Enters into $60 Million Term Loan Facility with Trinity Capital
10/11/2026
Initial drawdown of $42.5 million to refinance existing term loan REDWOOD CITY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and [...]
Researchers Discover Blood-Based Warning Signal for Ovarian Cancer at its Earliest, Precancerous Stage
10/11/2026
This first-of-its-kind breakthrough opens the possibility of detection years earlier compared to current methods NEWPORT BEACH, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Hoag researchers announced a first in the world [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum